Wednesday 31 May 2023

Globe Group Transforms Healthcare Access In The Philippines With KonsultaMD SuperApp






KUALA LUMPUR, May 30 (Bernama) -- The Globe Group, a leading digital solutions platform in the Philippines, has achieved a major milestone in its health tech initiative with the recent launch of the KonsultaMD SuperApp.

In a statement, the company said this groundbreaking app showcased new capabilities and a deeper and broader provider network, marking a significant advancement in the country’s healthcare industry.

“We have very exciting plans for KonsultaMD. It seeks to address a very big issue in the Philippines. With a ratio of one doctor for every 30,000 citizens, bringing healthcare access to the public is really our goal.

“The more we make the SuperApp easy to use and inject many more services into it, we think it is going to resonate with our customers and the public,” said Globe Group President and Chief Executive Officer, Ernest Cu.

The SuperApp is the next-generation iteration of KonsultaMD, a telehealth platform established by the Globe Group in 2015 that has since been instrumental in digitising healthcare services in the Philippines.

It bridges the gap between various health and medical services, consolidating them into one cohesive platform. This feature is particularly beneficial for those residing in remote areas where access to doctors is limited or none at all.

Bringing together services of top medical apps KonsultaMD, HealthNow and AIDE, the SuperApp features doctor consultations, a 24/7 online pharmacy with same-day delivery, at-home lab testing, diagnostics, wellness services, and physical therapy, among others.

The app also empowers users to consult with over 1,000 medical professionals with more than 40 specialisations including mental health, through on-demand video or chat from the comfort of their own homes.

The KonsultaMD SuperApp exemplifies the Globe’s commitment to making healthcare accessible to all, with plans for further expansion and improvement.

-- BERNAMA

No comments:

Post a Comment